Inventor · disambiguated record
Joseph Wrigglesworth
Also filed as: WRIGGLESWORTH JOSEPH · WRIGGLESWORTH JOSEPH WILLIAM
6 granted patents·10 pending applications·6 citations·filing 2015–2025
74Inventor score
Top patents by PatentIndex Score
16 records- 0190US12319680B2CompoundsSTEP PHARMA S A S·Filed 2022·Granted Jun 3, 2025·1 cites·1 claims
- 0286US11505547B2CompoundsSTEP PHARMA S A S·Filed 2018·Granted Nov 22, 2022·3 cites·20 claims
- 0374US2025263407A1CompoundsSTEP PHARMA S A A·Filed 2025·Application pending·0 cites
- 0473US11655246B2Aminothiazole compounds as inhibitors of CTPS1STEP PHARMA S A S·Filed 2018·Granted May 23, 2023·1 cites·19 claims
- 0569US10336702B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2015·Granted Jul 2, 2019·1 cites·28 claims
- 0663US10766861B2Pharmaceutically active compoundsBERGENBIO ASA·Filed 2019·Granted Sep 8, 2020·0 cites·9 claims
- 0762US2021070708A1Pharmaceutically Active CompoundsBERGENBIO ASA·Filed 2020·Application pending·0 cites
- 0858US2023192673A1CompoundsSTEP PHARMA S A S·Filed 2022·Application pending·0 cites
- 0957US12466810B2N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 1054US2024059691A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1149US2023020663A1Sulfonamide inhibitors as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1248US2023002352A1Sulfonamide derivatives as ctps1 inhibitorsSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1348US2022289727A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1447US2023086703A1N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseasesSTEP PHARMA S A S·Filed 2020·Application pending·0 cites
- 1546US2022363668A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1641US2021024507A1CompoundsSTEP PHARMA S A S·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Wrigglesworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →